These mutations can cause cancers to take root, or to become resilient to treatment. Through the use of medicines to inhibit the actions of Wip1 phosphatase, tumor growth can be stunted and tumours can be cured without developing resistance. That is a ground-breaking discovering that sheds light on how mutations in cancer can potentially be destroyed with drugs, enabling cancers to successfully be treated and removed, stopping relapses of tumour growth. Dr Dmitry Bulavin stated, ‘Our focus on Wip1 phosphatase for over ten years has revealed several key top features of this molecule. Our current findings strongly support the use of an anti-Wip1 drug for cancer treatment to be able to reduce a high rate of recurrence of mutations in the genome, which is one of the main motorists of tumour relapses.’ Prof Hong Wan Jin, Executive Director of IMCB, stated, ‘Dmitry provides been the pioneering driver in the mechanistic research of Wip1 phosphatase, which discovery can be monumental in offering novel understanding on the function of Wip1 in cancer at the genomic and systems amounts.The excess burden of stress and anxiety disorders makes life much more challenging which means this ‘double jeopardy’ must be addressed. The study authors viewed 269 Canadian adults who had been diagnosed with an inflammatory bowel disease. The researchers found that these individuals were 2 times more likely to have had generalized anxiety disorder at some time in their lives than adults without Crohn’s or colitis. And for women, the risk was four times greater than for males, the investigators found. In addition, people with an inflammatory bowel disease and a history of childhood sexual abuse had a sixfold increased threat of an anxiety disorder.